Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
4
×
glaxosmithkline
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
scott gottlieb
4
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
indiana blog main
indiana top stories
ipo
akcea therapeutics
amgen
cancer drugs
clinical study
clinical trials
commissioner
crispr
democrats
donald trump
What
roundup
4
×
bio
cancer
crispr
according
akcea
allogene
appetite
big
biotech
black
bosley's
bosley’s
bread
bridge
bucks
butter
buyout
cas
cases
cash
centers
ceo
cigarettes
control
crime
deaths
departure
diabetes
diamond’s
disease
diversity
drugs
editas
electronic
eli
exit
giant
grabbed
guiding
Language
unset
Current search:
fda
×
roundup
×
glaxosmithkline
×
" scott gottlieb "
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
